TrialBMJ open2021

A prospective, phase II, single-centre, cross-sectional, randomised study investigating Dehydroepiandrosterone supplementation and its Profile in Trauma: ADaPT.

Conor Bentley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.